Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brain tumors

J B Posner

    CA: a Cancer Journal for Clinicians
    |September 1, 1993
    PubMed
    Summary
    This summary is machine-generated.

    Brain tumor frequency is rising, but improved diagnostics and treatments offer hope. Physicians should remain vigilant for symptoms and embrace advanced therapies for better patient outcomes.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Les syndromes paranéoplasiques.

    Revue neurologique·2002
    Same author

    The photoreceptor cell-specific nuclear receptor is an autoantigen of paraneoplastic retinopathy.

    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2001
    Same author

    Molecular and clinical diversity in paraneoplastic immunity to Ma proteins.

    Annals of neurology·2001
    Same author

    Yet another paraneoplastic antibody.

    Annals of neurology·2001
    Same author

    Spontaneous intracranial hypotension: the broadening clinical and imaging spectrum of CSF leaks.

    Neurology·2001
    Same author

    Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies.

    Neurology·2000
    Same journal

    Serious mental illness and cancer: A call to action for equitable care.

    CA: a cancer journal for clinicians·2026
    Same journal

    Extranodal natural killer/T-cell lymphoma: From fatal to curable.

    CA: a cancer journal for clinicians·2026
    Same journal

    Data support longer recurrence-free survival with nivolumab than with ipilimumab for stage III or IV melanoma.

    CA: a cancer journal for clinicians·2026
    Same journal

    Study finds ovarian cancer survivors who are BRCA carriers have a relatively low risk of breast cancer.

    CA: a cancer journal for clinicians·2026
    Same journal

    Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma.

    CA: a cancer journal for clinicians·2026
    Same journal

    Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates.

    CA: a cancer journal for clinicians·2026
    See all related articles

    Area of Science:

    • Neurology
    • Oncology

    Background:

    • Studies indicate a rising incidence of brain tumors.
    • Concurrent advancements in diagnostic and therapeutic strategies are enhancing clinical management.

    Discussion:

    • Physicians are urged to maintain a high index of suspicion for brain tumor symptoms.
    • A positive outlook on treatment efficacy is encouraged.

    Key Insights:

    • Early detection and prompt intervention are crucial for managing brain tumors.
    • Referral to specialized investigative treatments is vital for continued progress.

    Outlook:

    • Continued research and clinical trials are essential for advancing brain tumor care.
    • Multidisciplinary approaches will further improve patient survival and quality of life.